Further exploring rm2 metrics for validation of QSPR models

Chemometrics and Intelligent Laboratory Systems

Volumn 107, Issue 1, 2011, Pages 194-205

  Ojha, Probir Kumar ^a   Mitra, Indrani ^a   Das, Rudra Narayan ^a   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

QSAR; QSPR; QSTR; Rm2; Validation

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; BINDING AFFINITY; CHEMICAL PROCEDURES; METRIC SYSTEM; NONBIOLOGICAL MODEL; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; QUANTITATIVE STRUCTURE TOXICITY RELATIONSHIP; RELIABILITY; VALIDATION STUDY;

EID: 79955650139     PISSN: 01697439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemolab.2011.03.011     Document Type: Article

References (134)

1. Buchwald P., Bodor N. Computer-aided drug design: the role of quantitative structure-property, structure-activity and structure-metabolism relationships (QSPR, QSAR, QSMR). Drugs Future 2002, 27:577-588.
2. Huang H.-J., Yu H.W., Chen C.-Y., Hsu C.-H., Chen H.-Y., Lee K.-J., Tsai F.-J., Chen C.Y.C. Current developments of computer-aided drug design. J. Taiwan Inst. Chem. Eng. 2010, 41:623-635.
3. Sprous D.G., Palmer R.K., Swanson J.T., Lawless M. QSAR in the pharmaceutical research setting: QSAR models for broad, large problems. Curr. Top. Med. Chem. 2010, 10:619-637.
4. Nantasenamat C., Isarankura-Na-Ayudhya C., Naenna T., Prachayasittikul V. A practical overview of quantitative structure-activity relationship. EXCLI J. 2009, 8:74-88.
5. Hu J., Zhang X., Wang Z. A review on progress in QSPR studies for surfactants. Int. J. Mol. Sci. 2010, 11:1020-1047.
6. Duchowicz P.R., Castro E.A. QSPR studies on aqueous solubilities of drug-like compounds. Int. J. Mol. Sci. 2009, 10:2558-2577.
7. Verma J., Khedkar V.M., Coutinho E.C. 3D-QSAR in drug design - a review. Curr. Top. Med. Chem. 2010, 10:95-115.
8. Lipinski C.A. Overview of hit to lead: the medicinal chemist's role from HTS retest to lead optimization hand off. Topics Med. Chem. 2010, 5:1-24.
9. Mager D.E. Quantitative structure-pharmacokinetic/pharmacodynamic relationships. Adv. Drug Deliv. Rev. 2006, 58:1326-1356.
10. Valerio L.G. Computational science in drug metabolism and toxicology. Expert Opin. Drug Metab. Toxicol. 2010, 6:781-784.
11. Bordás B., Komíves T., Lopata A. Ligand-based computer-aided pesticide design. A review of applications of the CoMFA and CoMSIA methodologies. Pest Manag. Sci. 2003, 59:393-400.
12. Fjodorova N., Novich M., Vrachko M., Smirnov V., Kharchevnikova N., Zholdakova Z., Novikov S., Skvortsova N., Filimonov D., Poroikov V., Benfenati E. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2008, 26:201-236.
13. Kar S., Roy K. Predictive toxicology using QSAR: a perspective. J. Indian Chem. Soc. 2010, 87:1455-1515.
14. Tropsha A. Best practices for QSAR model development, validation, and exploitation. Mol. Inf. 2010, 29:476-488.
15. Scior T., Medina-Franco J.L., Do Q.-T., Martínez-Mayorga K., Yunes Rojas J.A., Bernard P. How to recognize and workaround pitfalls in QSAR studies: a critical review. Curr. Med. Chem. 2009, 16:4297-4313.
16. Dearden J.C., Cronin M.T.D., Kaiser K.L.E. How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR). SAR QSAR Environ. Res. 2009, 20:241-266.
17. Roy K. On some aspects of validation of predictive quantitative structure-activity relationship models. Expert Opin. Drug Discov. 2007, 2:1567-1577.
18. Eriksson L., Jaworska J., Worth A.P., Cronin M.T., McDowell R.M., Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ. Health Perspect. 2003, 111:1361-1375.
19. Roy K., Leonard J.T. On selection of training and test sets for the development of predictive QSAR models. QSAR Comb. Sci. 2006, 25:235-251.
20. Roy P.P., Leonard J.T., Roy K. Exploring the impact of the size of training sets for the development of predictive QSAR models. Chemom. Intell. Lab. Syst. 2008, 90:31-42.
21. Wold S., Eriksson L. Statistical validation of QSAR results. Chemometric Methods in Molecular Design 1995, 309-318. Weinheim, VCH. H. van de Waterbeemd (Ed.).
22. Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb. Sci. 2007, 26:694-701.
23. 2 parameter for QSAR validation. J. Chem. Inf. Model. 2009, 49:1669-1678.
24. Hou T.-J., Wang J., Xu X. Applications of genetic algorithms on the structure-activity correlation study of a group of non-nucleoside HIV-1 inhibitors. Chemom. Intell. Lab. Syst. 1999, 45:303-310.
25. Depczynski U., Frost V.J., Molt K. Genetic algorithms applied to the selection of factors in principal component regression. Anal. Chim. Acta 2000, 420:217-227.
26. Todeschini R., Consonni V., Mauri A., Pavan M. Detecting "bad" regression models: multicriteria fitness functions in regression analysis. Anal. Chim. Acta 2004, 515:199-208.
27. Todeschini R. Data correlation, number of significant principal components and shape of molecules. The K correlation index. Anal. Chim. Acta 1997, 348:419-430.
28. Todeschini R., Consonni V., Maiocchi A. The K correlation index: theory development and its applications in chemometrics. Chemom. Intell. Lab. Syst. 1999, 46:13-29.
29. Miller A.J. Subset Selection in Regression 1990, Chapman & Hall, London, UK.
30. Wehrens R., Putter H., Buydens L.M.C. The bootstrap: a tutorial. Chemom. Intell. Lab. Syst. 2000, 54:35-52.
31. Kolossov E., Stanforth R. The quality of QSAR models: problems and solutions. SAR QSAR Environ. Res. 2007, 18:89-100.
32. Sagrado S., Cronin M.T.D. Application of the modeling power approach to variable subset selection for GA-PLS QSAR models. Anal. Chim. Acta 2008, 609:169-174.
33. Martens H., Martens M. Multivariate Analysis of Quality. An Introduction 2001, John Wiley & Sons Ltd, Chichester.
34. Sagrado S., Cronin M.T.D. Diagnostic tools to determine the quality of "transparent" regression-based QSARs: the "modeling power" plot. J. Chem. Inf. Model. 2006, 46:1523-1532.
35. 2!. J. Mol. Graph. Model. 2002, 20:269-276.
36. Hawkins D.M., Basak S.C., Mills D. Assessing model fit, by cross-validation. J. Chem. Inf. Comput. Sci. 2003, 43:579-586.
37. Roy P.P., Roy K. On some aspects of variable selection for partial least squares regression models. QSAR Comb. Sci. 2008, 27:302-313.
38. Roy P.P., Paul S., Mitra I., Roy K. On two novel parameters for validation of predictive QSAR models. Molecules 2009, 14:1660-1701.
39. Roy P.P., Roy K. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors. Chem. Biol. Drug Des. 2008, 72:370-382.
40. Paul S., Roy K. Exploring 2D and 3D QSARs of 2,4-diphenyl-1,3-oxazolines for ovicidal activity against Tetranychus urticae. QSAR Comb. Sci. 2009, 28:406-425.
41. Roy K., Paul S. Docking and 3D QSAR studies of protoporphyrinogen oxidase inhibitor 3H-pyrazolo[3,4-d][1,2,3]triazin-4-one derivatives. J. Mol. Model. 2010, 16:137-153.
42. Mitra I., Saha A., Roy K. Quantitative structure-activity relationship modeling of antioxidant activities of hydroxybenzalacetones using quantum chemical, physicochemical and spatial descriptors. Chem. Biol. Drug Des. 2009, 73:526-536.
43. Mitra I., Roy K., Saha A. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools. J. Comput. Chem. 2009, 30:2712-2722.
44. Roy K., Ghosh G. QSTR with extended topochemical atom indices 10. Modeling of toxicity of organic chemicals to humans using different chemometric tools. Chem. Biol. Drug Des. 2008, 72:383-394.
45. Roy K., Roy P.P. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques. Eur. J. Med. Chem. 2009, 44:2913-2922.
46. Roy K., Roy P.P. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques. Eur. J. Med. Chem. 2009, 44:1941-1951.
47. Roy K., Mitra I., Saha A. Molecular shape analysis of antioxidant and squalene synthase inhibitory activities of aromatic tetrahydro-1,4-oxazine derivatives. Chem. Biol. Drug Des. 2009, 74:507-516.
48. Roy K., Popelier P.L.A. Exploring predictive QSAR models for hepatocyte toxicity of phenols using QTMS descriptors. Bioorg. Med. Chem. Lett. 2008, 18:2604-2609.
49. Roy K., Popelier P.L.A. Exploring predictive QSAR models using quantum topological molecular similarity (QTMS) descriptors for toxicity of nitroaromatics to Saccharomyces cerevisiae. QSAR Comb. Sci. 2008, 27:1006-1012.
50. a) of phenols in different solvents. J. Phys. Org. Chem. 2009, 22:186-196.
51. 2 as a metric for validation of QSAR models. J. Chemometrics 2010, 24:22-33.
52. Roy P.P., Roy K. Classical and 3D-QSAR studies of cytochrome 17 inhibitor imidazole substituted biphenyls. Mol. Simul. 2010, 36:311-325.
53. Kar S., Roy K. QSAR modeling of toxicity of diverse organic chemicals to Daphnia magna using 2D and 3D descriptors. J. Hazard. Mater. 2010, 177:344-351.
54. Kar S., Harding A.P., Roy K., Popelier P.L.A. QSAR with quantum topological molecular similarity indices: toxicity of aromatic aldehydes to Tetrahymena pyriformis. SAR QSAR Environ. Res. 2010, 21:149-168.
55. Mitra I., Saha A., Roy K. Pharmacophore mapping of arylamino substituted benzo[b]thiophenes as free radical scavengers. J. Mol. Model. 2010, 16:1585-1596.
56. Roy P.P., Roy K. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors. J. Mol. Model. 2010, 16:597-1616.
57. Ray S., Roy P.P., Sengupta C., Roy K. Exploring QSAR of hydroxyphenylureas as antioxidants using physicochemical and electrotopological state (E-State) atom parameters. Mol. Simul. 2010, 36:484-492.
58. Roy P.P., Roy K. Pharmacophore mapping, molecular docking and QSAR studies of structurally diverse compounds as CYP2B6 inhibitors. Mol. Simul. 2010, 36:887-905.
59. Ojha P.K., Roy K. Chemometric modelling of antimalarial activity of aryltriazolylhydroxamates. Mol. Simul. 2010, 36:939-952.
60. Roy P.P., Roy K. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives. J. Pharm. Pharmacol. 2010, 62:1717-1728.
61. Mitra I., Saha A., Roy K. Exploring quantitative structure-activity relationship (QSAR) studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants. Mol. Simul. 2010, 36:1067-1107.
62. Roy K., Kar S. First report on interspecies quantitative correlation of ecotoxicity of pharmaceuticals. Chemosphere 2010, 81:738-747.
63. Ojha P.K., Roy K. Chemometric modeling, docking and in silico design of triazolopyrimidine based dihydroorotate dehydrogenase inhibitors as antimalarials. Eur. J. Med. Chem. 2010, 45:4645-4656.
64. Roy K., Das R.N. QSTR with extended topochemical atom (ETA) indices. 14. QSAR modeling of toxicity of aromatic aldehydes to Tetrahymena pyriformis. J. Hazard. Mater. 2010, 183:913-922.
65. Mitra I., Saha A., Roy K. Chemometric modeling of free radical scavenging activity of flavone derivatives. Eur. J. Med. Chem. 2010, 45:5071-5507.
66. Roy P.P., Roy K. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors. Chem. Biol. Drug Des. 2009, 73:442-455.
67. Roy P.P., Roy K. Exploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques. J. Enzyme Inhib. Med. Chem. 2010, 25:354-369.
68. Mandal A.S., Roy K. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives. Eur. J. Med. Chem. 2009, 44:1509-1524.
69. Roy K., Paul S. Docking and 3D-QSAR studies of acetohydroxy acid synthase inhibitor sulfonylurea derivatives. J. Mol. Model. 2010, 16:951-964.
70. Prankishore D., Balakumar C., Rao A.R., Roy P.P., Roy K. QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A3 receptor subtype. Bioorg. Med. Chem. Lett. 2011, 21:818-823.
71. Mitra I., Saha A., Roy K. Chemometric QSAR modeling and in silico design of antioxidant NO donor phenols. Sci. Pharm. 2011, 79:31-57.
72. Hu R., Doucet J.-P., Delamar M., Zhang R. QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on linear and nonlinear regression methods. Eur. J. Med. Chem. 2009, 44:2158-2171.
73. Toropov A.A., Toropova A.P., Benfenati E. QSPR modeling bioconcentration factor (BCF) by balance of correlations. Eur. J. Med. Chem. 2009, 44:2544-2551.
74. Toropov A.A., Toropova A.P., Benfenati E. QSPR modeling for enthalpies of formation of organometallic compoundsby means of SMILES-based optimal descriptors. Chem. Phys. Lett. 2008, 461:343-347.
75. Basu A., Jasu K., Jayaprakash V., Mishra N., Ojha P., Bhattacharya S. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives. Eur. J. Med. Chem. 2009, 44:2400-2407.
76. Lagos C.F., Caballero J., Gonzalez-Nilo F.D., Pessoa-Mahana C.D., Perez-Acle T. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Chem. Biol. Drug Des. 2008, 72:360-369.
77. Goodarzi M., Puggina de Freitas M. MIA-QSAR modelling of activities of a series of AZT analogues: bi- and multilinear PLS regression. Mol. Simul. 2010, 36:267-272.
78. Nargotra A., Koul S., Sharma S., Khan I.A., Kumar A., Thota N., Koul J.L., Taneja S.C., Qazi G.N. Quantitative structure-activity relationship (QSAR) of aryl alkenyl amides/imines for bacterial efflux pump inhibitors. Eur. J. Med. Chem. 2009, 44:229-238.
79. Nargotra A., Sharma S., Koul J.L., Sangwan P.L., Khan I.A., Kumar A., Taneja S.C., Koul S. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors. Eur. J. Med. Chem. 2009, 44:4128-4135.
80. Sharma B.S., Pilania P., Sarbhai K., Singh P., Prabhakar Y.S. Chemometric descriptors in modeling the carbonic anhydrase inhibition activity of sulfonamide and sulfamate derivatives. Mol. Divers. 2010, 14:371-384.
81. Liao S.Y., Chen J.C., Miao T.F., Shen Y., Zheng K.C. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors. J. Enzyme Inhib. Med. Chem. 2010, 25:421-429.
82. Naik P.K., Sidhura T., Singh H. Quantitative structure-activity relationship (QSAR) for insecticides: development of predictive in vivo insecticide activity models. SAR QSAR Environ. Res. 2009, 20:551-566.
83. Srivastava M., Singh H., Naik P.K. Quantitative structure-activity relationship (QSAR) of artemisinin: the development of predictive in vivo antimalarial activity models. J. Chemometrics 2009, 23:618-635.
84. Cheng J., Liu G., Zhang J., Xu Z., Tang Y. Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods. J. Mol. Model. 2011, 17:477-493.
85. Zeng H., Zhang H. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors. J. Mol. Graph. Model. 2010, 29:54-71.
86. Toropov A.A., Toropova A.P., Benfenati E., Leszczynska D., Leszczynski J. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J. Comput. Chem. 2010, 31:381-392.
87. Toropov A.A., Toropova A.P., Benfenati E., Leszczynska D., Leszczynski J. InChI-based optimal descriptors: QSAR analysis of fullerene [C60]-based HIV-1 PR inhibitors by correlation balance. Eur. J. Med. Chem. 2010, 45:1387-1394.
88. Lu P., Wei X., Zhang R. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase. Eur. J. Med. Chem. 2010, 45:3413-3419.
89. Dashtbozorgi Z., Golmohammadi H. Prediction of air to liver partition coefficient for volatile organic compounds using QSAR approaches. Eur. J. Med. Chem. 2010, 45:2182-2190.
90. Golmohammadi H., Safdari M. Quantitative structure-property relationship prediction of gas-to-chloroform partition coefficient using artificial neural network. Microchem. J. 2010, 95:140-151.
91. Toropov A.A., Toropova A.P., Benfenati E. QSPR modelling of normal boiling points and octanol/water partition coefficient for acyclic and cyclic hydrocarbons using SMILES-based optimal descriptors. Cent. Eur. J. Chem. 2010, 8:1047-1105.
92. Tromelin A., Merabtine Y., Andriot I., Lubbers S., Guichard E. Retention-release equilibrium of aroma compounds in polysaccharide gels: study by quantitative structure-activity/property relationships approach. Flavour. Fragr. J. 2010, 25:431-442.
93. Mallakpour S., Hatami M., Golmohammadi H. Prediction of inherent viscosity for polymers containing natural amino acids from the theoretical derived molecular descriptors. Polymer 2010, 51:3568-3574.
94. Arkan E., Shahlaei M., Pourhossein A., Fakhri K., Fassihi A. Validated QSAR analysis of some diaryl substituted pyrazoles as CCR2 inhibitors by various linear and nonlinear multivariate chemometrics methods. Eur. J. Med. Chem. 2010, 45:3394-3406.
95. Toropova A.P., Toropov A.A., Lombardo A., Roncaglioni A., Benfenati E., Gini G. A new bioconcentration factor model based on SMILES and indices of presence of atoms. Eur. J. Med. Chem. 2010, 45:4399-4402.
96. Ravichandran V., Mourya V.K., Agrawal R.K. Prediction of HIV-1 protease inhibitory activity of 4-hydroxy-5,6-dihydropyran-2-ones: QSAR study. J. Enzyme Inhib. Med. Chem. 2011, 26:288-294.
97. S. Kumar, V. Singh, M. Tiwari, QSAR modeling of the inhibition of reverse transcriptase enzyme with benzimidazolone analogs, Med. Chem. Res. (in press) http://dx.doi.org/10.1007/s00044-010-9406-2.
98. Akula N.V.M.K., Kumar S., Singh V., Tiwari M. Homology modeling and QSAR analysis of 1,3,4-thiadiazole and 1,3,4-triazole derivatives as carbonic anhydrase inhibitors. Indian J. Biochem. Biophys. 2010, 47:234-242.
99. Deeb O., Goodarzi M. Predicting the solubility of pesticide compounds in water using QSPR methods. Mol. Phys. 2010, 108:181-192.
100. Halder A.K., Jha T. Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity. Bioorg. Med. Chem. Lett. 2010, 20:6082-6087.
101. Shahlaei M., Sabet R., Ziari M.B., Moeinifard B., Fassihi A., Karbakhsh R. QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components. Eur. J. Med. Chem. 2010, 45:4499-4508.
102. P. Lan, J.-R. Sun, W.-N. Chen, P.-H. Sun, W.-M. Chen, Molecular modelling studies on d-annulated benzazepinones as VEGF-R2 kinase inhibitors using docking and 3D-QSAR, J. Enzyme Inhib. Med. Chem. (in press) http://dx.doi.org/10.3109/14756366.2010.513331.
103. Toropova A.P., Toropov A.A., Benfenati E., Leszczynska D., Leszczynski J. QSAR modeling of measured binding affinity for fullerene-based HIV-1 PR inhibitors by CORAL. J. Math. Chem. 2010, 48:959-987.
104. Goodarzi M., Freitas M.P. PLS and N-PLS-based MIA-QSTR modelling of the acute toxicities of phenylsulphonyl carboxylates to Vibrio fischeri. Mol. Simul. 2010, 36:953-959.
105. P. Lan, W.-N. Chen, Z.-J. Huang, P.-H. Sun, W.-M. Chen, Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking, J. Mol. Model. (in press) http://dx.doi.org/10.1007/s00894-010-0870-x.
106. Khosrokhavar R., Ghasemi J.B., Shiri F. 2D quantitative structure-property relationship study of mycotoxins by multiple linear regression and support vector machine. Int. J. Mol. Sci. 2010, 11:3052-3068.
107. Garriga M., Caballero J. Insights into the structure of urea-like compounds as inhibitors of the juvenile hormone epoxide hydrolase (JHEH) of the tobacco hornworm Manduca sexta: analysis of the binding modes and structure-activity relationships of the inhibitors by docking and CoMFA calculations. Chemopshere 2011, 82:1604-1613.
108. Deeb O., Khadikar P.V., Goodarzi M. QSPR modeling of bioconcentration factors of nonionic organic compounds. Environ. Health. Insights 2010, 4:33-47.
109. Lan P., Chen W.-N., Chen W.-M. Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora akinase inhibitors using 3D-QSAR and docking approaches. Eur. J. Med. Chem. 2011, 46:77-94.
110. Alavi A.H., Ameri M., Gandomi A.H., Mirzahosseini M.R. Formulation of flow number of asphalt mixes using a hybrid computational method. Constr. Build. Mater. 2011, 25:1338-1355.
111. Saghaie L., Shahlaei M., Fassihi A., Madadkar-Sobhani A., Gholivand M.B., Pourhossein A. QSAR analysis for some diaryl-substituted pyrazoles as CCR2 inhibitors by GA-stepwise MLR. Chem. Biol. Drug Des. 2011, 77:75-85.
112. Dashtbozorgi Z., Golmohammadi H. Quantitative structure-property relationship modeling of water-to-wet butyl acetate partition coefficient of 76 organic solutes using multiple linear regression and artificial neural network. J. Sep. Sci. 2010, 33:3800-3810.
113. Saghaie L., Shahlaei M., Madadkar-Sobhani A., Fassihi A. Application of partial least squares and radial basis function neural networks in multivariate imaging analysis-quantitative structure activity relationship: study of cyclin dependent kinase 4 inhibitors. J. Mol. Graph. Model. 2010, 29:518-528.
114. Golmohammadi H., Dashtbozorgi Z. Quantitative structure-property relationship studies of gas-to-wet butyl acetate partition coefficient of some organic compounds using genetic algorithm and artificial neural network. Struct. Chem. 2010, 21:1241-1252.
115. Ai Y., Song F.-J., Wang S.-T., Sun Q., Sun P.-H. Molecular modeling studies on 11H-dibenz[b, e]azepine and dibenz[b, f][1,4]oxazepine derivatives as potent agonists of the human TRPA1 receptor. Molecules 2010, 15:9364-9379.
116. Toropova A.P., Toropov A.A., Benfenati E., Gini G. Co-evolutions of correlations for QSAR of toxicity of organometallic and inorganic substances: an unexpected good prediction based on a model that seems untrustworthy. Chemom. Intell. Lab. Syst. 2011, 105:215-219.
117. Lee J.K., Song J.S., Nam K.D., Hahn H.-G., Yoon C.N. Substituent effects of thiazoline derivatives for fungicidal activities against Magnaporthe grisea. Pestic. Biochem. Physiol. 2011, 99:125-130.
118. Lan P., Xie M.-Q., Yao Y.-M., Chen W.-N., Chen W.-M. 3D-QSAR studies and molecular docking on [5-(4-amino-1Hbenzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1, 6-biphophatase inhibitors. J. Comput. Aided Mol. Des. 2010, 24:993-1008.
119. Najafi A., Ardakani S.S. 2D autocorrelation modelling of the anti-HIV HEPT analogues using multiple linear regression approaches. Mol. Simul. 2011, 37:72-83.
120. Sun J.-R., Lan P., Sun P.-H., Chen W.-M. 3D-QSAR and docking studies on pyrrolopyrimidine derivatives as LIM-kinase 2 inhibitors. Lett. Drug Des. Discov. 2011, 8:229-240.
121. Mollahasani A., Alavi A.H., Gandomi A.H. Empirical modeling of plate load test moduli of soil via gene expression programming. Comput. Geotech. 2011, 38:281-286.
122. Toropova A.P., Toropov A.A., Benfenati E., Gini G. Simplified molecular input-line entry system and international chemical identifier in the QSAR analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Chem. Biol. Dug Des. 2011, 77:343-360.
123. Toropova A.P., Toropov A.A., Diaza R.G., Benfenati E., Gini G. Analysis of the co-evolutions of correlations as a tool for QSAR-modeling of carcinogenicity: an unexpected good prediction based on a model that seems untrustworthy. Cent. Eur. J. Chem. 2011, 9:165-174.
124. Zandi-Atashbar N., Hemmateenejad B., Akhond M. Determination of amylose in Iranian rice by multivariate calibration of the surface plasmon resonance spectra of silver nanoparticles. Analyst 2011, 36:1760-1766.
125. Dorn C.P., Finke P.E., Oates B., Budhu R.J., Mills S.G., MacCoss M., Malkowitz L., Springer M.S., Daugherty B.L., Gould S.L., DeMartino J.A., Siciliano S.J., Carella A., Carver G., Holmes K., Danzeisen R., Hazuda D., Kessler J., Lineberger J., Miller M., Schleif W.A., Emini E.A. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl) butanes. Bioorg. Med. Chem. Lett. 2001, 11:259-264.
126. Finke P.E., Meurer L.C., Oates B., Mills S.G., MacCoss M., Malkowitz L., Springer M.S., Daugherty B.L., Gould S.L., DeMartino J.A., Sicilino S.J., Carella A., Carver G., Holmes K., Danzeisen R., Hazuda D., Kessler J., Lineberger J., Miller M., Schleif W.A., Emini E.A. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl) butanes. Bioorg. Med. Chem. Lett. 2001, 11:265-270.
127. Finke P.E., Meurer L.C., Oates B., Shah S.K., Loebach J.L., Mills S.G., MacCoss M., Castonguay L., Malkowitz L., Springer M.S., Gould S.L., DeMartino J.L. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl) amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl] butanes. Bioorg. Med. Chem. Lett. 2001, 11:2469-2473.
128. Finke P.E., Oates B., Mills S.G., MacCoss M., Malkowitz L., Springer M.S., Gould S.L., DeMartino J.A., Carella A., Carver G., Holmes K., Danzeisen R., Hazuda D., Kessle J., Lineberger J., Miller M., Schleif W.A., Emini E.A. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)-butanes. Bioorg. Med. Chem. Lett. 2001, 11:2475-2479.
129. Suzuki J., Tanji I., Ota Y., Toda K., Nakagawa Y. QSAR of 2,4-diphenyl-1,3-oxazolines for ovicidal activity against the two-spotted spider mite Tetranychus urticae. J. Pestic. Sci. 2006, 31:409-416.
130. Schultz T.W., Netzeva T.I., Cronin M.T.D. Selection of data sets for QSARs: analyses of Tetrahymena toxicity from aromatic compounds. SAR QSAR Environ. Res. 2003, 14:59-81.
131. Rogers D., Hopfinger A.J. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J. Chem. Inf. Comput. Sci. 1994, 34:854-866.
132. Cerius2 Version 4.10. Accelrys Inc.: San Diego, CA, USA, 2005.
133. Dougherty E.R., Barrera J., Brun M., Kim S., Cesar R.M., Chen Y., Bittner M., Trent J.M. Inference from clustering with application to gene-expression microarrays. J. Comput. Biol. 2002, 9:105-126.
134. Snedecor G.W., Cochran W.G. Statistical Methods 1989, Iowa State University Press, Ames. 8th ed.